Overview

A Study of the Safety and Efficacy of Bimatoprost in Patients With Glaucoma or Ocular Hypertension

Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
A one month study which will determine the safety and efficacy of bimatoprost eye drops in patients with glaucoma or ocular hypertension
Phase:
Phase 2
Details
Lead Sponsor:
Allergan
Treatments:
Bimatoprost
Ophthalmic Solutions
Tetrahydrozoline